Medications

Most US adults with T2D meet criteria for GLP-RAs, SGLT2is

Most U.S. adults with type 2 diabetes (T2D) meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), but fewer than 10 percent use ...

Diabetes

2009 to 2018 saw increase in total expenditure for insulin

The price of insulin has increased in the United States, with the burden of out-of-pocket (OOP) costs rising considerably among uninsured individuals, according to a study published online Feb. 7 in the Journal of Diabetes.

Health

Better targeted prediabetes care needed, say researchers

A more targeted approach to the screening and treatment of prediabetes is likely to be more effective at preventing type 2 diabetes and to reduce strain on primary health care sector resources, according to researchers at ...

page 126 from 610